LEGN
Legend Biotech Corp
Overview
Legend Biotech Corp is a Healthcare company operating in Biotechnology with a $5.19B market cap.
Most recent earnings call: Q1 FY26 on May 12, 2026.
11 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-1216 Q&A exchanges
- Q4 FY2025Earnings2026-03-1012 Q&A exchanges
- Q3 FY2025Earnings2025-11-1217 Q&A exchanges
- Q2 FY2025Earnings2025-08-1114 Q&A exchanges
- Q1 FY2025Earnings2025-05-1322 Q&A exchanges
- Q4 FY2024Earnings2025-03-1126 Q&A exchanges
- Q3 FY2024Earnings2024-11-1223 Q&A exchanges
- Q1 FY2024Earnings2024-05-1325 Q&A exchanges
- Q4 FY2023Earnings2024-03-1133 Q&A exchanges
- Q3 FY2023Earnings2023-11-2032 Q&A exchanges
- Q2 FY2023Earnings2023-08-1519 Q&A exchanges
History
Earnings history
Reported quarters with consensus, surprise, and 1-day reaction context.
Track Record
SampleSpoken Alpha tracks LEGN's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 9/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 3 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.27 | $3.40 | -3.7% | +1.8% | +4.1% |
| Q4 FY2026 | $3.22 | $3.20 | +0.7% | -5.6% | -4.7% |
| Q3 FY2026 | $3.24 | $3.44 | -5.7% | -6.7% | -8.1% |
| Q2 FY2026 | $3.05 | $3.31 | -8.0% | -2.9% | -2.9% |
| Q1 FY2025 | $3.14 | $3.28 | -4.3% | -8.0% | -9.7% |
| Q4 FY2025 | $3.05 | $3.38 | -9.9% | -0.6% | -0.7% |
| Q3 FY2025 | $3.29 | $3.38 | -2.7% | +2.4% | +4.6% |
| Q2 FY2025 | $3.23 | $3.37 | -4.1% | -3.5% | -3.6% |
| Q1 FY2024 | $3.17 | $3.31 | -4.2% | -1.9% | -1.3% |
| Q4 FY2024 | $3.18 | $3.32 | -4.2% | -7.7% | -9.3% |
Guidance change history
Sample- Q1 FY2026Maintained2026-04-15
- Q4 FY2026Maintained2026-13-15
- Q3 FY2026Lowered2026-10-15
- Q2 FY2026Lowered2026-07-15
- Q1 FY2025Lowered2025-04-15
- Q4 FY2025Lowered2025-13-15
- Q3 FY2025Maintained2025-10-15
- Q2 FY2025Lowered2025-07-15
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LEGN.
$ curl https://api.spokenalpha.com/v1/companies/LEGNFAQ
Frequently asked about LEGN
Where can I find Legend Biotech Corp's (LEGN) earnings call transcripts?
Spoken Alpha indexes LEGN's earnings call transcripts at https://spokenalpha.com/companies/LEGN. Each call links to attributed speakers and parsed analyst Q&A. Legend Biotech Corp's own investor relations page is at https://investors.legendbiotech.com/investor-relations.
When was Legend Biotech Corp's most recent earnings call?
Legend Biotech Corp (LEGN) held its most recent earnings call on 2026-05-12, covering fiscal Q1 2026.
What sector is LEGN in?
Legend Biotech Corp (LEGN) operates in the Healthcare sector (Biotechnology industry).